Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Retinal thickness in pediatric multiple sclerosis.
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Effects of propentofylline on CNS remyelination in the rat brainstem.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Optic Neuritis, its Differential Diagnosis and Management.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Multiple sclerosis: from molecules to treatment.
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Information provision for people with multiple sclerosis.
The endocannabinoid system: a putative role in neurodegenerative diseases.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Vitamin D and multiple sclerosis.
[Uveitis in multiple sclerosis : Overview and perspectives.]
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »